This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McGuinness, M. C.
Right arrow Articles by Smith, K. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McGuinness, M. C.
Right arrow Articles by Smith, K. D.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, January 2003, p. 744-753, Vol. 23, No. 2
0270-7306/03/$08.00+0     DOI: 10.1128/MCB.23.2.744-753.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Role of ALDP (ABCD1) and Mitochondria in X-Linked Adrenoleukodystrophy

M. C. McGuinness,1 J.-F. Lu,2 H.-P. Zhang,3 G.-X. Dong,3 A. K. Heinzer,2 P. A. Watkins,1 J. Powers,4 and K. D. Smith2,3*

Kennedy Krieger Institute and Departments of Neurology,1 Pediatrics,3 Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland,2 Department of Pathology, University of Rochester, Rochester, New York4

Received 23 May 2002/ Returned for modification 7 October 2002/ Accepted 23 October 2002

Peroxisomal disorders have been associated with malfunction of peroxisomal metabolic pathways, but the pathogenesis of these disorders is largely unknown. X-linked adrenoleukodystrophy (X-ALD) is associated with elevated levels of very-long-chain fatty acids (VLCFA; C>22:0) that have been attributed to reduced peroxisomal VLCFA ß-oxidation activity. Previously, our laboratory and others have reported elevated VLCFA levels and reduced peroxisomal VLCFA ß-oxidation in human and mouse X-ALD fibroblasts. In this study, we found normal levels of peroxisomal VLCFA ß-oxidation in tissues from ALD mice with elevated VLCFA levels. Treatment of ALD mice with pharmacological agents resulted in decreased VLCFA levels without a change in VLCFA ß-oxidation activity. These data indicate that ALDP does not determine the rate of VLCFA ß-oxidation and that VLCFA levels are not determined by the rate of VLCFA ß-oxidation. The rate of peroxisomal VLCFA ß-oxidation in human and mouse fibroblasts in vitro is affected by the rate of mitochondrial long-chain fatty acid ß-oxidation. We hypothesize that ALDP facilitates the interaction between peroxisomes and mitochondria, resulting, when ALDP is deficient in X-ALD, in increased VLCFA accumulation despite normal peroxisomal VLCFA ß-oxidation in ALD mouse tissues. In support of this hypothesis, mitochondrial structural abnormalities were observed in adrenal cortical cells of ALD mice.


* Corresponding author. Mailing address: Kennedy Krieger Institute, 707 North Broadway, Baltimore, MD 21205. Phone: (443) 923-2751. Fax: (443) 923-2752. E-mail: smithk{at}jhmi.edu.


Molecular and Cellular Biology, January 2003, p. 744-753, Vol. 23, No. 2
0022-538X/03/$08.00+0     DOI: 10.1128/MCB.23.2.744-753.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Brites, P., Mooyer, P. A. W., el Mrabet, L., Waterham, H. R., Wanders, R. J. A. (2009). Plasmalogens participate in very-long-chain fatty acid-induced pathology. Brain 132: 482-492 [Abstract] [Full Text]  
  • Fourcade, S., Ruiz, M., Camps, C., Schluter, A., Houten, S. M., Mooyer, P. A. W., Pampols, T., Dacremont, G., Wanders, R. J. A., Giros, M., Pujol, A. (2009). A key role for the peroxisomal ABCD2 transporter in fatty acid homeostasis. Am. J. Physiol. Endocrinol. Metab. 296: E211-E221 [Abstract] [Full Text]  
  • Hein, S., Schonfeld, P., Kahlert, S., Reiser, G. (2008). Toxic effects of X-linked adrenoleukodystrophy-associated, very long chain fatty acids on glial cells and neurons from rat hippocampus in culture. Hum Mol Genet 17: 1750-1761 [Abstract] [Full Text]  
  • Fourcade, S., Lopez-Erauskin, J., Galino, J., Duval, C., Naudi, A., Jove, M., Kemp, S., Villarroya, F., Ferrer, I., Pamplona, R., Portero-Otin, M., Pujol, A. (2008). Early oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy. Hum Mol Genet 17: 1762-1773 [Abstract] [Full Text]  
  • Oliveira, J. M. A., Chen, S., Almeida, S., Riley, R., Goncalves, J., Oliveira, C. R., Hayden, M. R., Nicholls, D. G., Ellerby, L. M., Rego, A. C. (2006). Mitochondrial-Dependent Ca2+ Handling in Huntington's Disease Striatal Cells: Effect of Histone Deacetylase Inhibitors. J. Neurosci. 26: 11174-11186 [Abstract] [Full Text]  
  • Ferrer, I., Kapfhammer, J. P., Hindelang, C., Kemp, S., Troffer-Charlier, N., Broccoli, V., Callyzot, N., Mooyer, P., Selhorst, J., Vreken, P., Wanders, R. J.A., Mandel, J. L., Pujol, A. (2005). Inactivation of the peroxisomal ABCD2 transporter in the mouse leads to late-onset ataxia involving mitochondria, Golgi and endoplasmic reticulum damage. Hum Mol Genet 14: 3565-3577 [Abstract] [Full Text]  
  • Asheuer, M., Bieche, I., Laurendeau, I., Moser, A., Hainque, B., Vidaud, M., Aubourg, P. (2005). Decreased expression of ABCD4 and BG1 genes early in the pathogenesis of X-linked adrenoleukodystrophy. Hum Mol Genet 14: 1293-1303 [Abstract] [Full Text]  
  • Oezen, I., Rossmanith, W., Forss-Petter, S., Kemp, S., Voigtlander, T., Moser-Thier, K., Wanders, R. J., Bittner, R. E., Berger, J. (2005). Accumulation of very long-chain fatty acids does not affect mitochondrial function in adrenoleukodystrophy protein deficiency. Hum Mol Genet 14: 1127-1137 [Abstract] [Full Text]  
  • Pujol, A., Ferrer, I., Camps, C., Metzger, E., Hindelang, C., Callizot, N., Ruiz, M., Pampols, T., Giros, M., Mandel, J. L. (2004). Functional overlap between ABCD1 (ALD) and ABCD2 (ALDR) transporters: a therapeutic target for X-adrenoleukodystrophy. Hum Mol Genet 13: 2997-3006 [Abstract] [Full Text]  
  • Hargrove, J. L., Greenspan, P., Hartle, D. K. (2004). Nutritional Significance and Metabolism of Very Long Chain Fatty Alcohols and Acids from Dietary Waxes. Exp. Biol. Med. 229: 215-226 [Abstract] [Full Text]  
  • Pei, Z., Oey, N. A., Zuidervaart, M. M., Jia, Z., Li, Y., Steinberg, S. J., Smith, K. D., Watkins, P. A. (2003). The Acyl-CoA Synthetase "Bubblegum" (Lipidosin): FURTHER CHARACTERIZATION AND ROLE IN NEURONAL FATTY ACID {beta}-OXIDATION. J. Biol. Chem. 278: 47070-47078 [Abstract] [Full Text]  
  • Maria, B. L., McCann Deidrick, K., Moser, H., Naidu, S. (2003). Leukodystrophies: Pathogenesis, Diagnosis, Strategies, Therapies, and Future Research Directions. J Child Neurol 18: 578-590  
  • Heinzer, A. K., Watkins, P. A., Lu, J.-F., Kemp, S., Moser, A. B., Li, Y. Y., Mihalik, S., Powers, J. M., Smith, K. D. (2003). A very long-chain acyl-CoA synthetase-deficient mouse and its relevance to X-linked adrenoleukodystrophy. Hum Mol Genet 12: 1145-1154 [Abstract] [Full Text]  
  • Ryu, H., Lee, J., Olofsson, B. A., Mwidau, A., Dedeoglu, A., Escudero, M., Flemington, E., Azizkhan-Clifford, J., Ferrante, R. J., Ratan, R. R. (2003). Histone deacetylase inhibitors prevent oxidative neuronal death independent of expanded polyglutamine repeats via an Sp1-dependent pathway. Proc. Natl. Acad. Sci. USA 100: 4281-4286 [Abstract] [Full Text]